GET THE APP

Polymeric nanoparticles encapsulating hydrophobic compounds for d | 18595
Journal of Chemical Engineering & Process Technology

Journal of Chemical Engineering & Process Technology
Open Access

ISSN: 2157-7048

+44-20-4587-4809

Polymeric nanoparticles encapsulating hydrophobic compounds for drug delivery


3rd International Conference on Chemical Engineering

October 02-04, 2017 Chicago, USA

Ying Liu

University of Illinois at Chicago, USA

Scientific Tracks Abstracts: J Chem Eng Process Technol

Abstract :

One of the biggest advantages of polymeric nanoparticles is the increase in solubility of hydrophobic compounds that they facilitate. Nearly 40% of all pharmaceutical compounds on the market (such as paclitaxel, rifampicin, digoxin and estrone) and 90% of newly developed compounds are hydrophobic and therefore difficult to deliver and maintain at sufficient bioavailability. Drugs requires toxic solvents and surfactants such as Cremophor and Tween, which often impair drug distribution and are associated with severe side effects. Nanomedicines, which do not require the use of toxic solvents, offer clear advantages. However, in over more than two decades, very few nanomedicines have been successfully developed and approved for clinical use. Those already on the market are either liposome based (such as Doxil�?® and Myocet�?®) or a protein-drug complex (such as Abraxane�?®). Although biodegradable and biocompatible polymers have significant advantages over liposome and protein delivery vehicles, such as better stability and robust molecular structure, polymeric nanoparticles have not been used beyond animal tests. The major difficulty is to completely control the physicochemical properties of the nanoparticles especially producing them in a large quantity. The Liu research group has developed a process of manipulating non-equilibrium structures of the polymeric nanoparticles via kinetic control by a sophisticated combination of mixing and spray drying. The Liu research group combined experimental and simulation tools to elucidate the selfassembly kinetics of polymeric micelles that control pharmaceutical nanoparticle physicochemical properties at multiple time scale form 100 ns to 10 s.

Biography :

Ying Liu has obtianed her BS in Engineering Mechanics from Tsinghua University in 2001 and her PhD in Chemical Engineering from Princeton University in 2007. She is a tenured Associate Professor at the University of Illinois at Chicago. Her research group is interested in understanding the competitive kinetics during material self assembly. She has developed a scalable, reproducible process to generate drug-delivery nanoparticles, based on comprehensive understanding of the competitive kinetics and molecular dynamics during nanoprecipitation.

Top